By clicking “Accept All Cookies”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. View our Privacy Policy for more information.
Female doctor with cancer patient discussing the option of immune checkpoint inhibitor therapyFemale doctor with cancer patient discussing the option of immune checkpoint inhibitor therapy

Diving Deep into Immune Checkpoint Inhibitors

This deep dive focuses on the value of ePROs in managing immune-related adverse effects and the impact this has on patient wellbeing and outcomes. It also considers the value and potential of the real-world data collected within the context of patients’ environments, and how this longitudinal view of patient wellbeing and treatment progression gives pharma companies a competitive advantage within the market.

by
Bronwyn Hemus
Be the first to know!
We'll send this deep dive to you as soon as it's published. Stay informed and subscribe.
Thank you! This deep dive is ready to download.
We'll send this deep dive to you as soon as it's published. Stay informed and subscribe.
Download PDF
Oops! Something went wrong while submitting the form.
you may also like
DTx User Acquisition Strategies: Best Practices for Market Access
Behavioral Economics: Merging Psychology and Economics for Lifestyle Interventions
Nonalcoholic Steatohepatitis (NASH): The ‘Other’ 21st Century Pandemic